FOLFOXIRI-based HAIC Combined With Fuquintinib as Late-line Treatment in Patients With CRLM：A Phase 2 Single-Arm Clinical Trial

Clinical trial NCT07024537 · COMPLETED

Trial details

NCT number: NCT07024537
Sponsor: Meng Qiu
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Neoplasms

Start date: 2023-01-12
Primary completion: 2025-05-30
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.